The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Aggressive pituitary adenomas—diagnosis and emerging treatments
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
Pituitary Adenomas with Invasion of the Cavernous Sinus Space
Knosp, E., Steiner, E., Kitz, K., & Matula, C. (1993) · Neurosurgery · doi:10.1097/00006123-199310000-00008 · Cited by 1,208
Pathology and genetics of tumours of endocrine organs
DeLellis, R. A. (2004) · Cited by 1,122
Advances in the Treatment of Prolactinomas
Gillam, M. P., Molitch, M. E., Lombardi, G., & Colao, A. (2006) · Endocrine Reviews · doi:10.1210/er.2005-9998 · Cited by 824
Guidelines for Acromegaly Management: An Update
Melmed, S., Colao, A., Barkan, A., Molitch, M., Grossman, A. B., Kleinberg, D., Clemmons, D., Chanson, P., Laws, E., Schlechte, J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2421 · Cited by 764
Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis
Kaur, B., Khwaja, F. W., Severson, E. A., Matheny, S. L., Brat, D. J., & Van Meir, E. G. (2005) · Neuro-Oncology · doi:10.1215/s1152851704001115 · Cited by 725
Acromegaly pathogenesis and treatment
Melmed, S. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39375 · Cited by 687
Transphenoidal Microsurgery of the Normal and Pathological Pituitary: Chapter X
Hardy, J. (1969) · Neurosurgery · doi:10.1093/neurosurgery/16.cn_suppl_1.185 · Cited by 640
Saeger, W., Lüdecke, D. K., Buchfelder, M., Fahlbusch, R., Quabbe, H.-J., & Petersenn, S. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02326 · Cited by 583
HYPOPRONOS, T. M. O., Trouillas, J., Roy, P., Sturm, N., Dantony, E., Cortet-Rudelli, C., Viennet, G., Bonneville, J.-F., Assaker, R., Auger, C., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1084-y · Cited by 545
Pathogenesis of pituitary tumors
Melmed, S. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.40 · Cited by 466
Thapar, K., Kovacs, K., Scheithauer, B. W., Stefaneanu, L., Horvath, E., Peter J., P., Murray, D., & Laws, E. R. (1996) · Neurosurgery · doi:10.1097/00006123-199601000-00024 · Cited by 462
Self-citationThe pathogenesis of pituitary tumours
Asa, S. L., & Ezzat, S. (2002) · Nature Reviews Cancer · doi:10.1038/nrc926 · Cited by 435
VEGF signalling: integration and multi-tasking in endothelial cell biology
Zachary, I. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311171 · Cited by 429
Fernandez, S., DeMarni Cromer, L., Borntrager, C., Swopes, R., Hanson, R. F., & Davis, J. L. (2013) · Clinical Case Studies · doi:10.1177/1534650112462623 · Cited by 427
Minniti, G., Traish, D., Ashley, S., Gonsalves, A., & Brada, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1152 · Cited by 377
Beckers, A., Aaltonen, L. A., Daly, A. F., & Karhu, A. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1013 · Cited by 360
Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly
Kopchick, J. J., Parkinson, C., Stevens, E. C., & Trainer, P. J. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0022 · Cited by 352
Kreutzer, J., Vance, M. L., Lopes, M. B. S., & Laws, E. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4072 · Cited by 341
Sarrazin, S., Adam, E., Lyon, M., Depontieu, F., Motte, V., Landolfi, C., Lortat-Jacob, H., Bechard, D., Lassalle, P., & Delehedde, M. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.08.004 · Cited by 337
Meij, B. P., Lopes, M.-B. S., Ellegala, D. B., Alden, T. D., & Laws, E. R. (2002) · Journal of Neurosurgery · doi:10.3171/jns.2002.96.2.0195 · Cited by 327
Diagnosis and Management of Pituitary Carcinomas
Kaltsas, G. A., Nomikos, P., Kontogeorgos, G., Buchfelder, M., & Grossman, A. B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2231 · Cited by 325
Thapar, K., Scheithauer, B. W., Kovacs, K., Pernicone, P. J., & Laws, E. R. (1996) · Neurosurgery · doi:10.1097/00006123-199604000-00027 · Cited by 321
Self-citationSex-Related Difference in the Growth of Prolactinomas: A Clinical and Proliferation Marker Study1
Delgrange, E., Trouillas, J., Maiter, D., Donckier, J., & Tourniaire, J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4088 · Cited by 277
The Pathogenesis of Pituitary Tumors
Asa, S. L., & Ezzat, S. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092259 · Cited by 263
Resistance to Somatostatin Analogs in Acromegaly
Colao, A., Auriemma, R. S., Lombardi, G., & Pivonello, R. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0002 · Cited by 257
EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas
Fukuoka, H., Cooper, O., Ben-Shlomo, A., Mamelak, A., Ren, S.-G., Bruyette, D., & Melmed, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci60417 · Cited by 254
van der Lely, A. J., Biller, B. M. K., Brue, T., Buchfelder, M., Ghigo, E., Gomez, R., Hey-Hadavi, J., Lundgren, F., Rajicic, N., Strasburger, C. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2508 · Cited by 252
Epidemiology and etiopathogenesis of pituitary adenomas
Aflorei, E. D., & Korbonits, M. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1354-5 · Cited by 229
Castinetti, F., Taieb, D., Kuhn, J.-M., Chanson, P., Tamura, M., Jaquet, P., Conte-Devolx, B., Régis, J., Dufour, H., & Brue, T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0311 · Cited by 225
H-ras mutations in human pituitary carcinoma metastases
Pei, L. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.4.842 · Cited by 216
Optimal role of temozolomide in the treatment of malignant gliomas
Stupp, R., van den Bent, M. J., & Hegi, M. E. (2005) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-005-0047-7 · Cited by 208
Pituitary Carcinoma: Difficult Diagnosis and Treatment
Heaney, A. P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2031 · Cited by 200
Raverot, G., Wierinckx, A., Dantony, E., Auger, C., Chapas, G., Villeneuve, L., Brue, T., Figarella-Branger, D., Roy, P., Jouanneau, E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1191 · Cited by 175
Wierinckx, A., Auger, C., Devauchelle, P., Reynaud, A., Chevallier, P., Jan, M., Perrin, G., Fèvre-Montange, M., Rey, C., Figarella-Branger, D., et al. (2007) · Endocrine-Related Cancer · doi:10.1677/erc-07-0062 · Cited by 171
Management of medically refractory prolactinoma
Molitch, M. E. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1270-8 · Cited by 165
Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status
McCormack, A. I., Wass, J. A. H., & Grossman, A. B. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02520.x · Cited by 161
Mechanisms of Disease: temozolomide and glioblastoma—look to the future
Mrugała, M. M., & Chamberlain, M. C. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1155 · Cited by 157
Clinicopathological Correlations in Pituitary Adenomas
Mete, Ö., & Asa, S. L. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00599.x · Cited by 156
Anti-VEGF therapy in pituitary carcinoma
Ortiz, L. D., Syro, L. V., Scheithauer, B. W., Erşen, A., Uribe, H., Fadul, C. E., Rotondo, F., Horváth, É., & Kovács, K. (2011) · Pituitary · doi:10.1007/s11102-011-0346-8 · Cited by 142
Self-citationOverexpression of endocan induces tumor formation.
Scherpereel, A., Gentina, T., Grigoriu, B. D., Sénéchal, S., Janin, A., Tsicopoulos, A., Plénat, F., Béchard, D., Tonnel, A., & Lassalle, P. (2003) · PubMed · Cited by 140
Crooke's Cell Adenoma of the Pituitary
George, D. H., Scheithauer, B. W., Kovács, K., Horváth, É., William F. Young, Lloyd, R. V., & Meyer, F. B. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200310000-00005 · Cited by 128
MGMT immunoexpression predicts responsiveness of pituitary tumors to temozolomide therapy
Kovács, K., Scheithauer, B. W., Lombardero, M., McLendon, R. E., Syro, L. V., Uribe, H., Ortiz, L. D., & Penagos, L. C. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0279-5 · Cited by 118
Self-citationProton Stereotactic Radiotherapy for Persistent Adrenocorticotropin-Producing Adenomas
Petit, J. H., Biller, B. M. K., Yock, T. I., Swearingen, B., Coen, J. J., Chapman, P. H., Ancukiewicz, M., Bussière, M. R., Klibanski, A., & Loeffler, J. S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1220 · Cited by 117
Role of stereotactic radiosurgery in the management of pituitary adenomas
Castinetti, F., Régis, J. M., Dufour, H., & Brue, T. C. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.4 · Cited by 112
Syro, L. V., Uribe, H., Penagos, L. C., Ortiz, L. D., Fadul, C. E., Horváth, É., & Kovács, K. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02653.x · Cited by 110
Self-citationEndocan Expression and Localization in Human Glioblastomas
Maurage, C., Adam, E., Minéo, J.-F., Sarrazin, S., Debunne, M., Siminski, R.-M., Baroncini, M., Lassalle, P., Blond, S., & Delehedde, M. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181a52a7f · Cited by 110
Kovács, K., Horváth, É., Syro, L. V., Uribe, H., Penagos, L. C., Ortiz, L. D., & Fadul, C. E. (2006) · Human Pathology · doi:10.1016/j.humpath.2006.07.014 · Cited by 110
Self-citationNew targeted therapies in pituitary carcinoma resistant to temozolomide
Jouanneau, E., Wierinckx, A., Ducray, F., Favrel, V., Borson‐Chazot, F., Honnorat, J., Trouillas, J., & Raverot, G. (2011) · Pituitary · doi:10.1007/s11102-011-0341-0 · Cited by 109
Treatment paradigms for pituitary adenomas: defining the roles of radiosurgery and radiation therapy
Ding, D., Starke, R. M., & Sheehan, J. P. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1262-8 · Cited by 109
Trouillas, J., Daniel, L., Mp, G., Tong, S., Gouvernet, J., Jouanneau, E., Jan, M., Perrin, G., Fischer, G., Tabarin, A., et al. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.98.5.1084 · Cited by 100
Predictive Markers of Pituitary Adenoma Behavior
Kontogeorgos, G. (2006) · Neuroendocrinology · doi:10.1159/000095526 · Cited by 97
Wagenmakers, M. A. E. M., Boogaarts, H. D., Roerink, S. H. P. P., Timmers, H. J. L. M., Stikkelbroeck, N. M. M. L., Smit, J. W. A., van Lindert, E. J., Netea-Maier, R. T., Grotenhuis, J. A., & Hermus, A. R. M. M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0325 · Cited by 89
Medical management of Cushing’s disease: what is the future?
Fleseriu, M., & Petersenn, S. (2012) · Pituitary · doi:10.1007/s11102-012-0397-5 · Cited by 89
Zacharia, B. E., Gulati, A. P., Bruce, J. N., Carminucci, A. S., Wardlaw, S. L., Siegelin, M. D., Remotti, H. E., Lignelli, A., & Fine, R. L. (2013) · Neurosurgery · doi:10.1227/neu.0000000000000251 · Cited by 88
Dopamine Receptor Expression and Function in Human Normal Adrenal Gland and Adrenal Tumors
Pivonello, R., Ferone, D., de Herder, W. W., de Krijger, R. R., Waaijers, M., Mooij, D. M., van Koetsveld, P. M., Barreca, A., De, M. D. B., Lombardi, G., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031746 · Cited by 84
Resistance to somatostatin analogs in acromegaly: An evolving concept?
Gola, M., Bonadonna, S., Mazziotti, G., Amato, G., & Giustina, A. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03349183 · Cited by 81
Managing Cushing’s disease: the state of the art
Colao, A., Boscaro, M., Ferone, D., & Casanueva, F. F. (2014) · Endocrine · doi:10.1007/s12020-013-0129-2 · Cited by 71
Endothelial Expression of Endocan Is Strongly Associated with Tumor Progression in Pituitary Adenoma
Cornélius, A., Cortet‐Rudelli, C., Assaker, R., Kerdraon, O., Gevaert, M. H., Prévot, V., Lassalle, P., Trouillas, J., Delehedde, M., & Maurage, C. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00578.x · Cited by 71
Fukuoka, H., Cooper, O. B., Mizutani, J., Tong, Y., Ren, S.-G., Bannykh, S., & Melmed, S. K. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0353 · Cited by 71
Treatment of Pituitary Tumors: Dopamine Agonists
Iván, G., Szigeti-Csúcs, N., Oláh, M., Nagy, G. M., & Góth, M. (2005) · Endocrine · doi:10.1385/endo:28:1:101 · Cited by 69
Are Markers of Proliferation Valuable in the Histological Assessment of Pituitary Tumours?
Turner, H. E., & Wass, J. A. H. (1999) · Pituitary · doi:10.1023/a:1009979128608 · Cited by 62
Pack, S., Qin, L.-X., Pak, E. D., Wang, Y., Ault, D. O., Mannan, P., Jaikumar, S., Stratakis, C. A., Oldfield, E. H., Zhuang, Z., et al. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20162 · Cited by 55
Horváth, É., & Kovács, K. (2006) · Neuroendocrinology · doi:10.1159/000095524 · Cited by 55
Angiogenesis in normal and neoplastic pituitary tissues
Lloyd, R. V., Vidal, S., Horváth, É., Kovács, K., & Scheithauer, B. W. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10263 · Cited by 54
Jevon, P. (2010) · Cited by 52
Pituitary senescence: The evolving role of Pttg
Chesnokova, V., & Melmed, S. K. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.02.012 · Cited by 50
Nelson syndrome: comprehensive review of pathophysiology, diagnosis, and management
Banasiak, M., & Malek, A. R. (2007) · Neurosurgical FOCUS · doi:10.3171/foc-07/09/e13 · Cited by 50
Repeat endoscopic transsphenoidal surgery for acromegaly: remission and complications
Wilson, T. J., McKean, E. L., Barkan, A. L., Chandler, W. F., & Sullivan, S. E. (2013) · Pituitary · doi:10.1007/s11102-012-0457-x · Cited by 47
Biomarkers of Pituitary Neoplasms: A Review (Part II): Errata
Sav, A., Rotondo, F., Syro, L. V., Scheithauer, B. W., & Kovács, K. (2011) · Neurosurgery · doi:10.1227/01.neu.0000393363.33165.ff · Cited by 44
Self-citationGenetics and Proteomics of Pituitary Tumors
Asa, S. L., & Ezzat, S. (2005) · Endocrine · doi:10.1385/endo:28:1:043 · Cited by 43
Microvascular morphometrics of the hypophysis and pituitary tumors: From bench to operating theatre
Ieva, A. D., Weckman, A. M., Michele, J. D., Rotondo, F., Grizzi, F., Kovács, K., & Cusimano, M. D. (2013) · Microvascular Research · doi:10.1016/j.mvr.2013.04.009 · Cited by 43
Self-citationEuclidean and fractal geometry of microvascular networks in normal and neoplastic pituitary tissue
Ieva, A. D., Grizzi, F., Gaetani, P., Goglia, U., Tschabitscher, M., Mortini, P., & y Baena, R. R. (2008) · Neurosurgical Review · doi:10.1007/s10143-008-0127-7 · Cited by 40
Barroso‐Sousa, R., Lerário, A. M., Evangelista, J., Papadia, C., Lourenço, D. M., Lin, C. S., Kulcsar, M. A. V., Fragoso, M. C. B. V., & Hoff, A. O. (2014) · Thyroid · doi:10.1089/thy.2013.0571 · Cited by 38
Gagliano, T., Filieri, C., Minoia, M., Buratto, M., Tagliati, F., Ambrosio, M. R., Lapparelli, M., Zoli, M., Frank, G., Uberti, E. C. D., et al. (2012) · Pituitary · doi:10.1007/s11102-012-0380-1 · Cited by 35
Prognostic Indicators in an Aggressive Pituitary Crooke's Cell Adenoma
Kovács, K., Diep, C. C., Horváth, É., Cusimano, M. D., Smyth, H. S., Coire, C. I., Lombardero, M., Scheithauer, B. W., & Lloyd, R. V. (2005) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100004583 · Cited by 21
Self-citationPituitary Tumour-Transforming Gene (PTTG) and Pituitary Senescence
Chesnokova, V., & Melmed, S. K. (2009) · Hormone Research in Paediatrics · doi:10.1159/000192443 · Cited by 19
A differential diagnosis of inherited endocrine tumors and their tumor counterparts
Toledo, S. P. A., Lourenço, D. M., & Toledo, R. A. (2013) · Clinics · doi:10.6061/clinics/2013(07)24 · Cited by 16
Treatment of Pituitary Tumors: Pegvisomant
Paisley, A. N., & Drake, W. M. (2005) · Endocrine · doi:10.1385/endo:28:1:111 · Cited by 11
The Place of Pegvisomant in the Management of Acromegaly
Parkinson, C., & Trainer, P. J. (2003) · The Endocrinologist · doi:10.1097/01.ten.0000089862.36519.81 · Cited by 8
Bisht, S., Feldmann, G., & Brossart, P. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.791281 · Cited by 8
Cited by
Raverot, G., Burman, P., McCormack, A., Heaney, A., Petersenn, S., Popovic, V., Trouillas, J., Dekkers, O. M., & _, _. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0796 · Cited by 595
Chatzellis, E., Alexandraki, K. I., Androulakis, I. I., & Kaltsas, G. (2015) · Neuroendocrinology · doi:10.1159/000371806 · Cited by 572
The 2017 World Health Organization classification of tumors of the pituitary gland: a summary
Lopes, M. B. S. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1769-8 · Cited by 548
Clinical Biology of the Pituitary Adenoma
Melmed, S., Kaiser, U. B., Lopes, M. B., Bertherat, J., Syro, L. V., Raverot, G., Reincke, M., Johannsson, G., Beckers, A., Fleseriu, M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac010 · Cited by 321
Self-citationMcCormack, A., Dekkers, O. M., Petersenn, S., Popovic, V., Trouillas, J., Raverot, G., Burman, P., _, _., _, _., Hubalewska-Dydejezky, A., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0933 · Cited by 287
Self-citation
Metadata
- Authors
- Di Ieva, A., Rotondo, F., Syro, L. V., Cusimano, M. D., & Kovacs, K.
- Venue
- Nature Reviews Endocrinology
- Published
- 2014-05-13
- Volume
- 10
- Issue
- 7
- Pages
- 423-435
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W2076285703
- Cited by
- 318
- References
- 81
- FWCI
- 4.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.